Li J - Search Results

1

Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer.

Li J, Wang R, Kong Y, Broman MM, Carlock C, Chen L, Li Z, Farah E, Ratliff TL, Liu X. Li J, et al. Among authors: li z. Mol Cancer Ther. 2017 Mar;16(3):469-479. doi: 10.1158/1535-7163.MCT-16-0361. Epub 2017 Jan 9. Mol Cancer Ther. 2017. PMID: 28069876 Free PMC article.

2

Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.

Li Z, Li J, Bi P, Lu Y, Burcham G, Elzey BD, Ratliff T, Konieczny SF, Ahmad N, Kuang S, Liu X. Li Z, et al. Among authors: li j. Mol Cell Biol. 2014 Oct 1;34(19):3642-61. doi: 10.1128/MCB.00814-14. Epub 2014 Jul 21. Mol Cell Biol. 2014. PMID: 25047839 Free PMC article.

3

Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.

Li J, Karki A, Hodges KB, Ahmad N, Zoubeidi A, Strebhardt K, Ratliff TL, Konieczny SF, Liu X. Li J, et al. Mol Cell Biol. 2015 Dec;35(24):4185-98. doi: 10.1128/MCB.00825-15. Epub 2015 Oct 5. Mol Cell Biol. 2015. PMID: 26438599 Free PMC article.

4

Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer.

Li J, Wang R, Schweickert PG, Karki A, Yang Y, Kong Y, Ahmad N, Konieczny SF, Liu X. Li J, et al. Cell Cycle. 2016;15(5):711-9. doi: 10.1080/15384101.2016.1148838. Cell Cycle. 2016. PMID: 26890815 Free PMC article.

5

Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.

Chen L, Li J, Farah E, Sarkar S, Ahmad N, Gupta S, Larner J, Liu X. Chen L, et al. Among authors: li j. Mol Cancer Ther. 2016 Sep;15(9):2107-18. doi: 10.1158/1535-7163.MCT-16-0241. Epub 2016 Jul 7. Mol Cancer Ther. 2016. PMID: 27390342 Free PMC article.

6

Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response.

Li Z, Li J, Kong Y, Yan S, Ahmad N, Liu X. Li Z, et al. Among authors: li j. Cancer Res. 2017 Jun 15;77(12):3169-3180. doi: 10.1158/0008-5472.CAN-16-2787. Epub 2017 May 16. Cancer Res. 2017. PMID: 28512243 Free PMC article.

7

Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.

Li Z, Liu J, Li J, Kong Y, Sandusky G, Rao X, Liu Y, Wan J, Liu X. Li Z, et al. Among authors: li j. J Biol Chem. 2017 Oct 20;292(42):17461-17472. doi: 10.1074/jbc.M117.810960. Epub 2017 Sep 12. J Biol Chem. 2017. PMID: 28900036 Free PMC article.

8

Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway.

Lee HJ, Li J, Vickman RE, Li J, Liu R, Durkes AC, Elzey BD, Yue S, Liu X, Ratliff TL, Cheng JX. Lee HJ, et al. Among authors: li j. Mol Cancer Res. 2018 Jun;16(6):974-985. doi: 10.1158/1541-7786.MCR-17-0665. Epub 2018 Mar 15. Mol Cancer Res. 2018. PMID: 29545473 Free PMC article.

9

Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer.

Zhang Z, Cheng L, Li J, Farah E, Atallah NM, Pascuzzi PE, Gupta S, Liu X. Zhang Z, et al. Among authors: li j. Cancer Res. 2018 Jun 15;78(12):3147-3162. doi: 10.1158/0008-5472.CAN-17-3006. Epub 2018 Apr 26. Cancer Res. 2018. PMID: 29700003 Free PMC article.

10

Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer.

Mao F, Li J, Luo Q, Wang R, Kong Y, Carlock C, Liu Z, Elzey BD, Liu X. Mao F, et al. Among authors: li j. Mol Cancer Ther. 2018 Jul;17(7):1554-1565. doi: 10.1158/1535-7163.MCT-17-0945. Epub 2018 May 1. Mol Cancer Ther. 2018. PMID: 29716963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191,684 results

Search Page

Filters